TIDMINHC

Induction Healthcare Group PLC

24 October 2019

24 October 2019

Induction Healthcare Group PLC

("Induction", the "Company" or the "Group")

Appointment of Dr Hugo Stephenson as acting Head of Product/Development

Induction Healthcare Group PLC, a leading healthcare technology company helping to streamline the delivery of care, announces that, to cover for ill health, Dr. Hugo Stephenson, Non-Executive Director, has taken up the role of interim Head of Product/Development.

Hugo is a technology entrepreneur and a practicing doctor in Australia. He is co-founder of Induction Healthcare and has a combination of healthcare and technology experience including as executive chairman and co-founder of DrugDev and Vice President at Quintiles.

The Board has approved this temporary management change to ensure continued effective operational performance pending the leadership of product/development being fulfilled internally or externally in relation to which a process is already underway.

-Ends-

ENQUIRIES

 
 Induction Healthcare Group PLC                     via FTI Consulting 
  Ibs Mahmood, Chief Executive Officer 
 Numis Securities (Nominated Adviser and 
  Broker) 
  James Black / Freddie Barnfield / Huw Jeremy 
  / Matthew Jones                                 +44 (0) 207 260 1000 
 FTI Consulting 
  Brett Pollard / Jamie Ricketts / Elena 
  Kalinskaya / Sam Purewal                        +44 (0) 203 727 1000 
 

About Induction

Induction Healthcare Group PLC is a leading healthcare technology company focused on helping healthcare professionals to streamline the delivery of care. The Group's technology enables healthcare professionals to save time and deliver care more effectively and to identify ways to allocate resources more efficiently.

The Group is initially targeting improving the way healthcare professionals communicate with each other through its Induction Switch app that provides a telephone directory (allowing healthcare professionals to easily find extension telephone numbers), messaging and an administration portal (to share and view hospital guidelines), all in a secure and regulatory compliant setting.

As at 19 September 2019, the Induction Switch app had registered users surpassing 100,000, most of which are UK hospital doctors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAEAKEDAFFNFFF

(END) Dow Jones Newswires

October 24, 2019 05:00 ET (09:00 GMT)

Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Induction Healthcare
Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Induction Healthcare